2019 Portfolio Update
The year is over so here is my full year 2019 portfolio update. I added a couple of new positions in Q4 2019. Here is my complete portfolio. Full Year…
The year is over so here is my full year 2019 portfolio update. I added a couple of new positions in Q4 2019. Here is my complete portfolio. Full Year…
2019 was a fun year of investing for me and I feel like I learned a lot of investing lessons that I hope to carry forward. I have recognized some…
On November 21st, 2019, CO2 Gro Inc. released its updated financials for Q3 2019. Although there isn't a whole lot to examine in their financials there are some meaningful news…
On November 26th, 2019, RIWI announced its Q3 2019 financials. RIWI is a disruptive data collection company based out of Toronto. They use random domain intercept technology to collect predictive…
Something I have been paying a lot more attention to is microcap executive compensation. I believe there is a correlation between executive compensation and shareholder return. My opinion is based…
For Part 1 of my Crescita analysis (CTX.TO, CRRTF) please read the previous post. I own shares of CTX.TO. Crescita Therapeutics (CTX.TO, CRRTF) is a publicly-traded, Canadian commercial dermatology company…
I just finished the New York Times bestseller Red Notice. I can't recall how the book got on my radar but it was an interesting read and a welcome break…
Here is my Q3 2019 portfolio update. At the end of each year, I will give a comparison of how my portfolio and each individual stock performed compared to the…
Crescita Therapeutics (TSX: CTX) is a publicly-traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions…
Motley Fool Rule Breakers is a paid stock picking service provided by the Motley Fool Company. Co-Ceo David Gardner makes the selections in this service. In comparison in their most…